Index

Index sorted by Drug, Company, and Foundations and Nonprofit/Government Organizations [ Read More ]

Support Services Directory

Recent advancements in cancer treatments have revolutionized cancer care. The use of genetic mutations to guide therapy, and continued innovations in immunotherapies, targeted drugs, radiation, and chemotherapy have improved patients’ health outcomes and quality of life. [ Read More ]

The 4th Annual Guide to Patient Support Services a Practical Tool for Oncology Practices

The year 2017 witnessed continued innovation in cancer therapies reaching new milestones, with many new cancer treatments entering the market, especially in immunotherapy, with the first ever 2 gene therapies approved by the FDA. Nevertheless, the high costs of oncology drugs can present serious barriers to patients who depend on those therapies. The financial and emotional stresses associated with the high cost of cancer care can be detrimental to the clinical outcomes for patients dealing with a life-threatening disease. [ Read More ]

The Patient Access Network Foundation: Support Services for Patients with Cancer

Oncology Practice Management recently interviewed Daniel J. Klein, President and Chief Executive Officer of Patient Access Network (PAN) Foundation, a nonprofit organization dedicated to helping federally and commercially insured people living with life-threatening, chronic, and rare diseases, including cancer, with paying their out-of-pocket costs for their prescribed medications.

In this interview, Mr Klein highlights the support services the PAN Foundation provides to patients and providers dealing with cancer and how to take advantage of these services.

[ Read More ]

The Patient Advocate Foundation: Helping Patients to Access Effective Care

In this interview, Oncology Practice Management recently asked Alan Balch, PhD, Chief Executive Officer of the Patient Advocate Foundation (PAF), a nonprofit organization, to discuss the support services PAF offers to patients with cancer. Dr Balch highlights the financial and other support services that make PAF especially helpful for patients who need help in accessing their medications and the care they need. [ Read More ]

AbbVie

AbbVie, together with Genentech, has developed and is marketing the oncology drug Venclexta (venetoclax). Venclexta is indicated for patients with chronic lymphocytic leukemia and 17p deletion who have received at least 1 previous treatment. [ Read More ]

Amgen

Amgen Assist 360 provides several support services for insured, uninsured, and underinsured patients who encounter financial hardships and cannot afford the Amgen medications they are prescribed, including Amgen FIRST STEP and the Amgen Safety Net Foundation. [ Read More ]

Astellas

Astellas Pharma’s Xtandi Support Solutions program offers patient assistance services to eligible patients who are prescribed Xtandi (enza­lutamide) for metastatic castration-resistant prostate cancer. [ Read More ]

AstraZeneca

AstraZeneca, through its Access 360 and AZ & Me programs, offers a range of patient support programs and drug-specific patient savings programs to help patients access affordable AstraZeneca medications [ Read More ]